Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Barnett S. Pitzele is active.

Publication


Featured researches published by Barnett S. Pitzele.


Organic and Biomolecular Chemistry | 2003

4-Fluorinated L-lysine analogs as selective i-NOS inhibitors: methodology for introducing fluorine into the lysine side chain.

E. Ann Hallinan; Steven W. Kramer; Stephen C. Houdek; William M. Moore; Gina M. Jerome; Dale P. Spangler; Anna M. Stevens; Huey S. Shieh; Pamela T. Manning; Barnett S. Pitzele

In the literature, the introduction of fluorine into bioactive molecules has been known to enhance the biological activity relative to the parent molecule. Described in this article is the synthesis of 4R-fluoro-L-NIL (12) and 4,4-difluoro-L-NIL (23) as part of our iNOS program. Both 12 and 23 were found to be selective iNOS inhibitors as shown in Table 2 below. Secondarily, methodology to synthesize orthogonally protected 4-fluoro-L-lysine and 4,4-difluoro-L-lysine has been developed.


Tetrahedron | 1976

γ-alkylation of α,β-unsaturated acids : A technique of stereospecific isoprenoid homologation

Barnett S. Pitzele; John S. Baran; D.H. Steinman

Abstract This paper describes the synthesis of various isomers of farnesol by means of two different isoprenoid homologations; the γ-alkylation of 2-butynoic acid and the γ-alkylation of 3-methyl crotonic acid.


Bioorganic & Medicinal Chemistry Letters | 2001

Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase

Alan E. Moormann; Sue Metz; Mihaly V. Toth; William M. Moore; Gina M. Jerome; Christine M. Kornmeier; Pamela T. Manning; Donald W. Hansen; Barnett S. Pitzele; Ronald Keith Webber

The potency and selectivity of a series of 5-hetero-2-iminohexahydroazepines were examined as inhibitors of the three human NOS isoforms. The effect of ring substitution of the 5-carbon for a heteroatom is presented. Potencies (IC(50)s) for these inhibitors are in the low micromolar range for hi-NOS with some examples exhibiting a 500x selectivity versus hec-NOS.


Bioorganic & Medicinal Chemistry Letters | 2002

3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: a potent and highly selective inducible nitric oxide synthase inhibitor.

Sofya Tsymbalov; Timothy J. Hagen; William M. Moore; Gina M. Jerome; Jane R. Connor; Pamela T. Manning; Barnett S. Pitzele; E. Ann Hallinan

(3S,4S,5R)-2-Imino-4-methyl-5-pentyl-3-pyrrolidinol hydrochloride (1) is a potent inducible nitric oxide synthase (i-NOS) inhibitor that has three times the selectivity of its parent, (+)-cis-4-methyl-5-pentylpyrrolidin-2-imine hydrochloride (2).


Heterocycles | 1994

The N-Boc Group as an Activator for the a-Lithiation of Carbamates: Synthesis of 11-Substituted Dibenzoxazepines

Timothy J. Hagen; Michael F. Rafferty; Joe T. Collins; Danny J. Garland; James J. Li; Monica B. Norton; David B. Reitz; Sofya Tsymbalov; Barnett S. Pitzele; E. Ann Hallinan

A series of 11-substituted dibenzoxazepines was prepared via α-lithiation utilizing the N-Boc group as an activator. The N-Boc group directs metalation of 5 by n-BuLi to the benzylic C-11 carbon. For 6 which contains 1,3 interrelated directed metalation groups, metalation with n-BuLi occurs at both the 11- and 9- positions. The regioselectivity for the lithiation of 6 can be increased to a ratio of 97:3, by employing LDA as the base, thus providing a convenient and general route to 11-substituted 8-chloro-dibenzoxazepines. By the proper choice of the base, the regioselectivity of lithiation-substitution reactions in the pharmaceutically important heteroaromatic ring systems (5) and (6) can be controlled. The N-Boc group can be readily removed with mild acid treatment


Heteroatom Chemistry | 2000

Syntheses of new racemic NG‐(1‐iminoethyl)phosphalysine derivatives as potential inhibitors of nitric oxide synthase

Mark A. Massa; Barnett S. Pitzele; Gina M. Jerome; William M. Moore; Pamela T. Manning; James A. Sikorski

The efficient syntheses of three new racemic NG-(1-iminoethyl)phosphalysine derivatives are reported where the lysine carboxylate group is systematically replaced by phosphonic acid, 4, methyl phosphinic acid, 5, and phosphinic acid, 6. These compounds were evaluated as potential inhibitors of the three isoforms of human nitric oxide synthase.


Archive | 1994

Amidino derivatives useful as nitric oxide synthase inhibitors

Donald W. Hansen; Mark G. Currie; E. Ann Hallinan; Kam F. Fok; Timothy J. Hagen; Arija A. Bergmanis; Steven W. Kramer; Len F. Lee; Suzanne Metz; William M. Moore; Karen B. Peterson; Barnett S. Pitzele; Dale P. Spangler; R. Keith Webber; Mihaly V. Toth; Mahima Trivedi; Foe S. Tjoeng


Archive | 1992

Opioid agonist compounds

Michael S. Dappen; Barnett S. Pitzele; Michael F. Rafferty


Journal of Medicinal Chemistry | 1998

Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms.

Webber Rk; Suzanne Metz; William M. Moore; Connor; Mark G. Currie; Kam F. Fok; Timothy J. Hagen; Donald W. Hansen; Gina M. Jerome; Pamela T. Manning; Barnett S. Pitzele; Mihaly V. Toth; Mahima Trivedi; Zupec Me; Foe S. Tjoeng


Journal of Medicinal Chemistry | 2002

Synthesis and Biological Characterization of L-N6-(1-Iminoethyl)lysine 5-Tetrazole-amide, a Prodrug of a Selective iNOS Inhibitor

E. Ann Hallinan; Sofya Tsymbalov; Clifford R. Dorn; Barnett S. Pitzele; Donald W. Hansen; William M. Moore; Gina M. Jerome; Jane R. Connor; Linda F. Branson; Deborah L. Widomski; Yan Zhang; Mark G. Currie; Pamela T. Manning

Collaboration


Dive into the Barnett S. Pitzele's collaboration.

Researchain Logo
Decentralizing Knowledge